The EGFR pathway is an essential signaling system in animals, whose core components are the epidermal growth factors (EGF ligands) and their trans-membrane tyrosine kinase receptors (EGFRs). Despite extensive knowledge in classical model organisms, little is known of the composition and function of the EGFR pathway in most animal lineages. Here, we have performed an extensive search for the presence of EGFRs and EGF ligands in representative species of most major animal clades, with special focus on the planarian Schmidtea mediterranea. With the exception of placozoans and cnidarians, we found that the EGFR pathway is potentially present in all other analyzed animal groups, and has experienced frequent independent expansions. We further characterized the expression domains of the EGFR/EGF identified in S. mediterranea, revealing a wide variety of patterns and localization in almost all planarian tissues. Finally, functional experiments suggest an interaction between one of the previously described receptors, Smed-egfr-5, and the newly found ligand Smed-egf-6. Our findings provide the most comprehensive overview to date of the EGFR pathway, and indicate that the last common metazoan ancestor had an initial complement of one EGFR and one putative EGF ligand, which was often expanded or lost during animal evolution.
In multicellular organisms, communication between individual cells is essential for the regulation of complex biological processes, such as growth, differentiation, tissue renewal, and cell death. In animals, the receptor tyrosine kinases (RTKs) are well known mediators of intercellular signaling1,2. In particular, the epidermal growth factor receptor (EGFR) subfamily is the central constituent of a signaling pathway involved in multiple embryonic and adult processes3. For instance, it controls the fate and proliferation of multiple cell types in the invertebrate model systems Caenorhabditis elegans and Drosophila melanogaster4,5, and exerts a crucial function in the development and morphogenesis of many organs in vertebrate animals, such as the skin6, intestine7, the central nervous system8 and mammary gland9, as well as in the progression of prevalent human diseases, such as cancers3.
Although constitutive and ligand-independent activations of the EGFR pathway have been described, especially in the context of several cancers10, EGFR signaling depends mainly on the binding of a peptide growth factor of the EGF-family to an EGFR. This interaction induces the phosphorylation of the cytoplasmic tyrosine kinase (TK) domain of the EGFR, and the subsequent activation of different intercellular transduction cascades that regulate downstream effector genes11. Despite slight differences, all identified EGFRs share conserved structural features that distinguish them from other RTKs. All consist of an extracellular ligand-binding domain containing two or more cysteine rich clusters, a trans-membrane region, and a cytoplasmic domain with tyrosine kinase activity12. The nematode C. elegans and the fruit fly D. melanogaster have one single receptor (let-23 and der, respectively)13,14, but vertebrates have four EGFR classes: egfr (ErbB-1/her1), ErbB-2 (her2), ErbB-3 (her3) and ErbB-4 (her4)15. With respect to the ligands, all known EGF proteins are synthesized as transmembrane precursors characterized by the presence of an EGF-like domain (in some cases multiple EGF-like domains) in their extracellular region16. Cleavage of this membrane precursor in the extracellular milieu releases the active EGF ligand, which contains a conserved cysteine-containing motif that confers binding specificity17. While C. elegans has only one ligand (lin-3)18, D. melanogaster has four (spitz, vein, gurken and keren)4,19, and vertebrates have an expanded set of 11 EGF ligands: the epidermal growth factor (egf), amphiregulin (areg), epigen, epiregulin (epr), betacellulin (btc), heparin-binding EGF-like growth factor (hb-egf), transforming growth factor-α (TGFα) and four neuregulins (nrg1-4)16,20,21. Notably, an additional extracellular immunoglobulin-like domain is present in the D. melanogaster ligand vein, and in the vertebrate ligands nrg1 and nrg2, which also contain an intracellular neuregulin domain21,22.
In recent years, research on the planarian flatworm Schmidtea mediterranea (Platyhelminthes)23,24,25 has clarified the role of the EGFR signaling pathway in the Spiralia (previously referred to as Lophotrochozoa26), which together with the Ecdysozoa (e.g. C. elegans and D. melanogaster) and the Deuterostomia (e.g. vertebrates) form the three major groups of bilaterally symmetrical animals26. The planarian S. mediterranea is a well-established model in regenerative research, due to its striking ability to regrow any missing body part after injury27. Previous studies have identified four EGFRs in S. mediterranea (Smed-egfr-1, Smed-egfr-2, Smed-egfr-3 and Smed-egfr-5), but only one representative in the related parasitic flatworm species Echinococcus multilocularis (EmER) and Schistosoma mansoni (SER)23,25,28,29. Additionally, one putative EGF ligand (Smed-epiregulin-1) and a neuregulin-like ligand (Smed-nrg-1) have been identified30,31. Interestingly, the planarian EGFRs and ligand show a broad spectrum of expression patterns23,25,30 and are functionally implicated in the regeneration and homeostasis of different organs and cell types, such as the pharynx, the excretory and nervous systems, and the eye pigment cells23,25. Despite this progress in a member of the Spiralia, the presence, composition, and role of the EGFR pathway in most animal lineages –apart from the classical developmental and biomedical model systems–, is virtually unknown. Accordingly, we also know little about the evolution and functional diversification of this important signaling pathway during animal history.
In this study, we use the numerous accessible genomic and transcriptomic datasets to present phylogenetic analyses of the two key EGFR signaling pathway components –EGFRs and EGF ligands– in representatives of most major animal clades, together with the identification and characterization of two new EGFRs and nine new EGF ligands in the planarian S. mediterranea. Our findings indicate that S. mediterranea has a total of six EGFRs and nine EGF ligands, which exhibit a wide variety of expression patterns. Silencing of the newly identified EGF ligand Smed-egf-6 by RNA interference phenocopies the previously reported role of the EGFR Smed-egfr-525, suggesting a mechanistic connection between them. Altogether, our data permit us to hypothesize that the last common metazoan ancestor had one EGFR and one probable EGF-like ligand, and that the neuregulin-like type of ligands appeared in the last common bilaterian ancestor. Our study indicates that the evolutionary history of the EGFR pathway is characterized by frequent independent expansions of an originally minimal set of one EGFR and one (Metazoa) or two (Bilateria) EGF ligands. These data may help us to understand how this signaling pathway has acquired its broad diversity of physiological roles, as observed in extant animals.
Results and Discussion
Distribution and diversification of EGFRs in Metazoa
A thorough investigation of the genomic and transcriptomic data available for a wide diversity of animal lineages revealed that the EGFR subfamily of RTKs is present in almost all animal groups (Table 1), including ctenophores and sponges32, the two earliest branching animal clades26. Significant exceptions are cnidarians and placozoans, for which the absence of an EGFR ortholog has been previously reported33,34, and the gastrotrich Lepidodermella squamata. In this latter case, further sequencing and sampling efforts will be required to confirm this absence. The orthology assignment of all identified EGFR sequences was confirmed by a phylogenetic analysis of the tyrosine kinase (TK) domain, including representatives of all metazoan RTKs subfamilies and the RTKs of the amoebozoan Acanthamoeba castellanii (Supplementary Figure 1). This analysis was corroborated by a further phylogenetic analysis of the whole EGFR sequence (Fig. 1).
Despite particular relationships are not strongly supported in our orthology analysis, the number, distribution (Table 1) and general phylogenetic relationships (Fig. 1) of the EGFRs suggest that a single copy of this RTK was present in the last common metazoan ancestor, as well as at the base of the three major bilaterian groups: the Deuterostomia, the Ecdysozoa and the Spiralia. Subsequent independent expansions occurred in certain bilaterian lineages, such as xenacoelomorphs, tunicates, vertebrates, platyhelminthes, clitellate annelids, molluscs, and bryozoans. While the overall domain architecture of all EGFRs is highly similar (Fig. 1), the number of extracellular cysteine rich domains can vary considerably (Table 1). The previous assumption that vertebrate and invertebrate EGFRs differ in the number of cysteine rich domains (2 in vertebrate EGFRs; 3 in the EGFRs of D. melanogaster and C. elegans)35 is not supported by our data. In fact, the copy number of this extracellular domain seems to oscillate between 2 and 5, and rather than being species-specific, it appears to vary even between paralog EGFRs (Table 1). Interestingly, we found EGFR sequences with potentially inactive (or at least highly divergent) tyrosine kinase domains in the planarian S. mediterranea and the limpet Lottia gigantea (Table 1) (Supplementary Figure 2). This condition is similar to the situation observed in the human Erbb3 receptor36,37,38,39, and suggests that EGFR duplication in some spiralian lineages has been accompanied by the evolution of alternative regulation/modulation of EGFR signaling.
The EGFR complement of the planarian S. mediterranea
The re-investigation of the most recent transcriptome and genome resources of S. mediterranea40,41 using the newly identified EGFR sequences of the early branching polyclad flatworm Prostheceraeus vittatus (this study) as queries42, allowed us to recover two new EGFRs, which we named Smed-egfr-4 and Smed-egfr-6. As such, S. mediterranea includes six EGFRs in its genome, which is in the range of the other flatworm species that we analyzed: 8 EGFRs in the macrostomid Macrostomum lignano, 6 EGFRs in the polyclad P. vittatus, and 3 EGFRs in the parasites Schistosoma mansoni and Echinoccocus multilocularis (Table 1). An orthology analysis of the recovered flatworm EGFRs using other spiralian sequences as an outgroup (Fig. 2A) revealed that the expansions observed in Macrostomorpha, Polycladida and Neoophora (planarians and parasites) occurred independently, and thus there was likely one single EGFR copy in the last common platyhelminth ancestor, as in most other spiralian lineages. Importantly, planarian EGFRs group in three distinct clades, which we named group A, B, and C (Fig. 2A). The receptor Smed-egfr-1 is the single representative of group A (Fig. 2B). Group B includes the receptors Smed-egfr-2, Smed-egfr-3 and Smed-egfr-4, which exhibit canonical domain architectures, but a varying number of cysteine rich domains (Fig. 2B). Finally, group C consists of the receptors Smed-egfr-5 and Smed-egfr-6, the latter with key amino acid substitutions that may inactivate the ATP binding and active sites of the tyrosine kinase domain (Supplementary Figure 2).
Previous studies characterized the expression and function of the S. mediterranea EGFRs Smed-egfr-1, Smed-egfr-2, Smed-egfr-3 and Smed-egfr-5 in adult worms23,25. The receptor Smed-egfr-1 is expressed in the gut, pharynx, and eye pigment cells (Fig. 3A), and is required for the proper regeneration and homeostasis of the eyes, pharynx and gut (Fig. 3B)23,31. The paralog Smed-egfr-2 is expressed in the gut (Fig. 3A), and no apparent phenotype is observed after silencing23. The receptor Smed-egfr-3 is detected in the neoblast, pharynx and the cephalic ganglia (Fig. 3A) and is required for the proper growth of the blastema during regeneration, probably by regulating cell differentiation (Fig. 3B)23,24. Finally, Smed-egfr-5 is expressed in the excretory system (Fig. 3A) and is required for its proper regeneration (Fig. 3B)25. We performed whole mount in situ hybridization experiments to characterize the expression domains of the newly identified Smed-egfr-4 and Smed-egfr-6 genes. The receptor Smed-egfr-4 was mainly expressed in the central nervous system and pharynx, and weakly in the mesenchyme (Fig. 3A). The paralog Smed-egfr-6 was expressed in the pharynx and in a discrete pattern throughout the body (Fig. 3A). The silencing by RNAi of either Smed-egfr-4 or Smed-egfr-6 gave no perceivable external phenotypes (data not shown). Altogether, our findings support that the expansion of EGFRs that occurred in the lineages leading to S. mediterranea has been accompanied by a molecular, transcriptional and functional diversification of the different paralogs. However, further expression and functional analysis in other platyhelminthes and spiralian lineages are essential to better understand the ancestral role of the EGFR in these organisms.
Distribution of EGF ligands in Metazoa
The evolution of EGF ligands has been mostly studied in vertebrates, C. elegans, and D. melanogaster17,43,44,45. Because the only common feature to all ligands is the presence of an EGF domain, which is a motif present in a tremendous diversity of proteins17, we designed a conservative approach to identify new putative EGF ligands. Candidate genes had to be full length (see Material and Methods for the very few exceptions to this criteria), with only one EGF motif, and with domain architectures consistent with the structures of already known EGF ligands17. Our in silico searches reported 75 new potential EGF ligands (Table 2), in addition to those already described for Homo sapiens, C. elegans, D. melanogaster and Tribolium castaneum. Consistent with the absence of an EGFR, we did not recover any putative EGF ligands in the cnidarian databases analyzed. An analysis of domain compositions revealed two basic architectures: the EGF-type of ligands, with only an EGF domain and a varying number of transmembrane regions (from zero, in soluble candidates, to two); and the neuregulin-type (NRG-type) of ligands, which showed an EGF domain combined with an immunoglobulin I-set domain and a transmembrane region (Supplementary Figure 3). Representatives of the first group are the H. sapiens EGF ligands egf, hb-egf, TGFα, areg, epr, btc, and epigen, lin-3 from C. elegans, and the D. melanogaster ligands gurken, keren and spitz. Examples of the NRG-type of EGF ligands are the human nrg-1 and nrg-2, and the D. melanogaster gene vein. While we were able to recover putative ligands of the EGF-type in almost all animal lineages analyzed –with the exception of the sea urchin Strongylocentrotus purpuratus and the phoronid Phoronopsis harmerii–, NRG-type ligands were only identified in bilaterian groups (Table 2).
Phylogenetic studies of the EGF ligands tend to analyze vertebrate and invertebrate sequences separately43, to avoid artifacts associated with the low phylogenetic signal obtained from the EGF domain. Therefore, we first performed a sequence-similarity-based clustering analysis of all retrieved putative EGF ligands, with the aim of supporting our domain-based classification (Supplementary Figure 4). NRG-type ligands clustered together, which supported considering them a bona fide subtype, but most EGF-type ligands were highly dispersed and weakly interconnected. The failure to recover a well-defined cluster of EGF-type ligands is another sign of the low phylogenetic signal of EGF ligands. This is most likely caused by the extreme variability in the protein structure of these genes, and the fact that the only common region –the EGF motif– is also very variable, beyond the few conserved amino acids that are invariable among all species (e.g. the six conserved cysteines17). Following the results of the clustering analysis, we studied the orthology assignments of the two major subtypes of EGF ligands separately (Fig. 4A,B) (Supplementary Figures 5 and 6). In line with previous reports43 and our findings after the sequence-similarity analysis, we could not resolve the deepest relationships between all metazoan EGF-type putative ligands. Regarding the NRG-type, we could tentatively assign orthology relationships between the two ambulacrarian NRGs, the two ecdysozoan NRGs, and the four human NRGs, which confirmed a previous analysis of vertebrate EGF ligands43. All things considered, the distribution of EGF ligands, the domain architecture of the diversity of candidate genes, and the clustering and phylogenetic analyses, support dividing the EGF ligands into two separate classes: the EGF-type and the NRG-type. The presence of the EGF-type in the ctenophore Mnemiopsis leidyi, the sponge Amphimedon queenslandica and the placozoan Trichoplax adhaerens indicates that this was likely the ancestral EGFR ligand. However, further biochemical analyses are needed to confirm that this putative EGF ligand actually binds the EGFRs present in the ctenophore and the sponge, and thus the existence of a truly functional EGFR signaling pathway in these early branching animal lineages. Consistent with its presence in xenacoelomorphs and most other bilaterian groups, the NRG-type appears to be an innovation of Bilateria.
The EGF ligand complement of S. mediterranea
Our search for EGF ligands in the genome40 and publicly available transcriptomes of S. mediterranea41 reported nine candidate genes (Table 2), including the previously described Smed-epiregulin-130 and the recently identified Smed-nrg-131. Eight of these were of the EGF-type, and only one was of the NRG-type. Smed-epiregulin-1 belongs to the EGF-type, and given the fact that the gene epiregulin is a vertebrate-specific paralog of an ancestral EGF-like gene44, we renamed this planarian candidate as Smed-egf-1. We named the rest of the planarian putative EGF-type ligands consecutively, from Smed-egf-2 to Smed-egf-8, and the only NRG-type ligand as Smed-nrg-131. The phylogenetic analysis of spiralian putative EGF-type ligands did not recover monophyly of the platyhelminth sequences (Fig. 5A), most probably due to the low phylogenetic signal of the EGF domain. However, this analysis suggested three planarian-specific clusters (Fig. 5A). The first group includes from Smed-egf-1 to Smed-egf-5, which are all characterized by presenting the EGF domain upstream of the transmembrane region. The second cluster consists of Smed-egf-6 and Smed-egf-7, and both are secreted ligands without transmembrane domain. Finally, Smed-egf-8 branches independently from other planarian EGF ligands in our orthology analyses, and has a domain architecture similar to the group of Smed-egf-1 to Smed-egf-5. As observed in the current genomic version40, the presence of introns in all the identified ligands and the six EGFRs suggests that the expansion of these two gene families did not occur by retroposition, but rather by gene duplications.
We next analyzed the expression of the identified putative EGF ligands in adult intact specimens of S. mediterranea (Fig. 6A). The ligands Smed-egf-1 and Smed-egf-2 were expressed in the gut, and Smed-egf-3 transcripts localized to the pharynx and in scattered mesenchymal cells around it, a pattern reminiscent of other pharynx-related genes, such as foxA46,47. Expression of Smed-egf-4 was detected in the pharynx, the mesenchyme around it, and the central nervous system (Fig. 6A), while Smed-egf-5 was expressed in the pharynx and esophagus (Fig. 6A). The putative ligand Smed-egf-6 was mainly detected in isolated cells of the lateral margin of the planarian, at the boundary between the dorsal and the ventral epidermis. Notably, the expression was stronger and the number of cells greater in the margin of the head, where Smed-egf-6 also localized to isolated cells of the anterior dorsal midline (Fig. 6A; inset). The EGF-type putative ligand Smed-egf-7 was expressed in the brain –strongly in the posterior region of the cephalic ganglia–, pharynx and the mesenchyme around it (Fig. 6A), and Smed-egf-8 was detected in the mesenchyme and pharynx. Finally, Smed-nrg-1 was expressed in the pharynx and mesenchyme (Fig. 6A). Altogether, these findings show that the nine putative EGF ligands of S. mediterranea exhibit a broad diversity of expression patterns, relating mostly to pharyngeal and gut tissues as well as the nervous system (Fig. 6B).
To gain a better understanding of the function of these candidate ligands, and their potential relationships with the described EGFRs, we performed single RNAi gene silencing by double stranded RNA (dsRNA) injections and assessed the consequences during anterior and posterior regeneration. Out of the eight putative EGF-type ligands, we only observed an apparent phenotype after Smed-egf-6 RNAi, which could indicate some level of functional redundancy between these ligands. However, we cannot discard the possibility that those for which we did not observe any phenotype could be involved in more cell-specific roles that we could not discriminate at the gross morphological level. Silencing of Smed-egf-6 did not affect the regeneration of missing structures, but rather, produced edemas (Fig. 7A), a phenotype remarkably similar to the one observed after Smed-egfr-5 RNAi25. To determine if the swollen phenotype was caused by defects in the excretory system, as described for Smed-egfr-5(RNAi) animals, we analyzed the expression of the specific protonephridial marker carbonic anhydrase (CAVII-1)25. As expected, Smed-egf-6(RNAi) regenerating animals showed a reduced number of, and aberrant, protonephridial tubules (Fig. 7A), suggesting that the edemas were caused by an abnormal regeneration of this organ system. We further confirmed these results during adult homeostasis in intact animals (Fig. 7B). These findings suggest that Smed-egf-6 could act through Smed-egfr-5 to regulate planarian excretory system regeneration and homeostasis. We have also recently reported that silencing Smed-nrg-1 causes an abnormal regeneration of the eyes, gut and pharynx31, suggesting that this putative ligand signals via the Smed-egfr-1 receptor. Although we have only observed an apparent phenotype for two of the nine putative ligands, their roles during regeneration and homeostasis are consistent with those previously assigned to planarian EGFRs. We propose that this concurrence validates our bioinformatic approach for ligand identification.
In summary, the demonstrable relevance of the EGFR pathway in the fields of biomedicine, cancer and developmental biology3 contrasts with our limited understanding of the evolution and functional diversification of this pathway in the animal tree of life. Our broad genomic survey of representatives of 19 different major animal clades suggests that the EGFR pathway probably evolved within the metazoan stem lineage (Fig. 8)32 and comprised an EGF receptor and a single putative EGF-like ligand, as observed in extant ctenophores and sponges. The EGFR pathway appears to be missing from placozoan and cnidarian lineages, while the presence of a neuregulin-like putative ligand in the vast majority of bilaterian species analyzed indicate that this new type of EGFR ligand appeared together with the Bilateria (Fig. 8). Subsequently, the EGFR and/or the EGF ligands have frequently become expanded in many bilaterian lineages, and new modes of signaling modulation (e.g. via inactive Tyr kinase domains) have appeared (Fig. 8). The planarian S. mediterranea (Platyhelminthes) is a prototype of these evolutionary events, because it exhibits an EGFR pathway with 6 EGF receptors –including one putative inactive EGFR–, and 9 EGF ligands –1 neuregulin-like and 8 EGF-like. Gene expression and functional analyses demonstrate that these components are detected in most of the differentiated tissues of the planarian (Figs 3 and 6)23,25, and control the regeneration and homeostasis of different organs, tissues, and body regions of the animal (Fig. 7), probably by regulating cell differentiation23,24,25,31. Altogether, our findings deliver an expanded and detailed evolutionary framework that makes a significant contribution towards our understanding of the molecular and functional diversification of the EGFR pathway in animals, and which will improve future comparisons between emerging biomedical systems, such as planarians, and better-established classical model organisms.
Database searching and phylogenetic analyses
All potential EGFRs and EGF ligands were identified by BLAST and HMMER searches against completed genome/transcriptome databases publicly available or that are being generated in our laboratories (Supplementary Material). Searches were conducted with default parameters and an inclusive E-value of 0.05. For the EGFRs, only sequences including the tyrosine kinase domain (complete or partial) were considered. Regarding the EGF ligands, only full-length sequences with coherent domain architectures were used in subsequent analyses. The only exceptions for this rule were the previously described planarian ligand (Smed-epiregulin-1)30, which lacks the N-terminal region, as well as the newly identified NRG-type ligand of X. bockii and EGF-type ligands of P. caudatus, H. spinulosus and S. kowalevskii, which all lack the very C-terminal end of the protein but give high BLAST and HMMER similarities to other described EGF ligands. The retrieved sequences were aligned using MAFFT v748. Poorly aligned regions of the multiple protein alignment of EGFRs were removed with Gblocks49 using the least stringent parameters. Only the EGF domain of the candidate EGF ligands was used for phylogenetic analyses. In the case of the NRG-type ligands, also the immunoglobulin domain was included in the analyses. Maximum likelihood (ML) phylogenetic analyses were conducted with RAxML v850 with the autoMRE option on to calculate the bootstrap support values. Bayesian inference analyses were performed with MrBayes v351 using two parallel runs, sampling every 100 generations. Bayesian posterior probabilities were used for assessing the statistical support of each bipartition.The domain architecture of each identified sequence was analyzed using InterProScan 552 and SignalP 4.1 53, and manually verified when automatic predictions where dubious. The domain information was used to assess the reliability of each sequence of the initial dataset and to help define protein families according to their architectural coherence.
Clustering analysis of the potential EGF ligands
A sequence-similarity-based (PSI-BLAST P-values) clustering approach to analyze the global phylogenetic relationships of the potential EGF ligands was performed with CLANS54. A cutting P-value of 1e-15 was applied.
Asexual S. mediterranea from the BCN-10 clonal line were maintained in artificial water55. Animals were fed with veal liver and starved for at least 1 week before conducting any experiment.
Gene cloning and whole-mount in situ hybridization
The newly identified planarian EGFRs and putative EGF ligands were isolated by gene-specific PCR and cloned into the pGEM-T vector (Promega). Whole-mount in situ hybridization experiments were performed as previously described56,57. All samples were observed through a Leica MZ16F stereomicroscope and images were captured with a ProgResC3 camera (Jenoptik). Images were processed with Photoshop CS6 (Adobe) and figures were mounted in Illustrator CS6 (Adobe). Brightness/contrast and color balance adjustments were applied to the whole image, not parts.
Silencing by RNAi was performed as described elsewhere58. Control animals were injected with double-stranded RNA for green fluorescent protein (GFP). In Smed-egf-6(RNAi) experiments, all animals received one round of injection (each consisting of three injections on consecutive days). For experiments on regenerating animals, planarians were amputated 1 day after the last injection and allowed to regenerate 14 days before fixation. For homeostatic experiments dsRNA-injected animals were kept in starvation for 2 weeks before fixation. In the RNAi experiments of the other components of the EGFR pathway in S. mediterranea identified in this study, all animals received two rounds of injections (each consisting of three injections on consecutive days) separated by 3–4 days and were amputated 1 day after both rounds of injection. Since no phenotype was observed during regeneration with these genes, we did not proceed with homeostatic RNAi experiments.
How to cite this article: Barberán, S. et al. Evolution of the EGFR pathway in Metazoa and its diversification in the planarian Schmidtea mediterranea. Sci. Rep. 6, 28071; doi: 10.1038/srep28071 (2016).
We thank Andreas Hejnol and all the members of Emili Saló’s lab for support and discussion, as well as D. Thiel for help with the CLAN analysis. We thank Gemma S. Richards for a critical read of the manuscript. All identified sequences are available in Additional File 7. Additionally, S. mediterranea sequences were deposited in GenBank (accession numbers egf-1 to egf-7: KU850488 to KU850494; egf-8: KT947468; nrg-1: KU850495; egfr-1 to egfr-6: KU850496 to KU850501). This study was funded by grants, BFU2012-31701 and BFU2015-65704-P(Ministerio de Economia y Competitividad/Feder (Spain)) and 2009-SGR-1018 from the Generalitat de Catalunya to FC. SB was supported by a FI fellowship from the Generalitat de Catalunya and a collaboration fellowship from IBUB. JMMD was supported by Marie Curie IEF 329024 fellowship and Sars core budget. The authors declare no competing financial interests.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/